Blood transfusion: What does it mean to the surgeon?

Digestive Surgery

Volumn 14, Issue 1, 1997, Pages 2-8

  Lont, L E ^a   Busch, O R C ^b   Van Eijck, C H J ^a   Marquet, R L ^a   Jeekel, J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b IKAZIA HOSPITAL   (Netherlands)

Author keywords

Blood transfusion; Cancer prognosis; Postoperative infectious complications

Indexed keywords

BLEEDING; BLOOD TRANSFUSION; CANCER; CANCER SURGERY; COLORECTAL CANCER; HUMAN; IMMUNE DEFICIENCY; IMMUNOMODULATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PROGNOSIS; REVIEW; SURGEON;

EID: 0031060229     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000172504     Document Type: Article

References (83)

1. Agarwal N, Murphy JG, Cayten G. Stahl WM: Blood transfusion increases the risk of infection after trauma. Arch Surg 1993; 128:171-177.
2. Ford CD, van Moorleghem G, Menhove RL: Blood transfusions and postoperative wound infection. Surgery 1993:113:603-607.
3. Edna TH, Bjerkeset T, Svinsas M, Drogset JO: Association between transfusion of stored blood and bacterial infective complications after biliary operations. Eur J Surg 1994:160: 357-362.
4. Edna TH, Vada K, Hesselberg F, Mjolnerod OK: Blood transfusion and survival following surgery for renal carcinoma. BrJ Urol 1992:70: 135-138.
5. Chung M, Steinmetz OK, Gordon PH: Perioperative blood transfusion and outcome after resection for colorectal carcinoma. Br J Surg 1993:80:427-432.
6. Edna TH, Bjerkeset T: Association between blood transfusion and infection in injured patients. J Trauma 1992:33:659-661.
7. Jensen LS, Andersen AJ, Christiansen PM, et al: Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992:79:513-516.
8. Tartter PI: The association of perioperative blood transfusion with colorectal cancer recurrence. Ann Surg 1992:216:633-638.
9. Walker RH: Special report: Transfusion risks. Am J Clin Pathol 1987:88:374-378.
10. Ho DD, Pomerantz RJ, Kaplan JC: Pathogenesis of infection with human immunodeficiency virus. N Engl J Med 1987;317:278-286.
11. Henle W, Henle G, Seriba M, et al: Antibody responses to the Epstein-Barr virus and cytomegalovirus after openheart and other surgery. N Engl J Med 1970;282:1068-1074.
12. Okochi K, Sato M, Himona Y: A retrospective study on transmission of adult T-cell leukemia virus by blood transfusion: Seroconversion in recipients. Vox Sang 1984:465:245-253.
13. Cohen ND, Munoz A, Reitz BA, et al: Transmission of retroviruses by blood transfusion of screened blood in patients undergoing cardiac surgery. N Engl J Med 1989:320:1172-1175.
14. van der Poel CL, Reesink HW, Schaasberg W, et al: Ineffcctivityofblood seropositive for hepatitis C virus antibodies. Lancet 1990:335: 558-560.
15. Opelz G, Scngar DPS, Mickey MR, Terasaki PI: Effect of blood transfusion on subsequent kidney transplants. Transplant Proc 1973:5: 253-259.
16. Fiseher E, Lenhard V, Seifert P, Kluge A, Johannsen R: Blood transfusion-induced suppression of cellular immunity in man. Hum Immunol 1980:3:187-193.
17. Watson MA, Briggs JD, Diamandopoulos AA, Hamilton DNH, Dick HM: Endogenous cell-mediated immunity, blood transfusion and outcome of renal transplantation. Lancet 1979;ii: 1323-1326.
18. Tartter PI, Heimann TM, Aufses AH: Blood transfusion, skin test reactivity, and lymphocytes in inflammmatory bowel disease. Am J Surg 1986:151:358-361.
19. Klatzmann D, Bensussan A, Gluckman JC, et al: Blood transfusion suppress lymphocyte reactivity in uraemic patients. II: Evidence for soluble suppressor factors. Transplantation 1983;36:337-340.
20. Waymack JP, Gallon L, Barcelli U, Trocki O, Alexander JW: Effect of blood transfusions on immune function. Ill: Alterations in macrophage arachidonic acid metabolism. Arch Surg 1987;122:56-60.
21. Ford CD, Warnick CT, Sheets S, Quist R. Stevens LE: Bkxid transfusions lower natural killer cell activity. Transplant Proc 1987; 19:1456-1457.
22. Kaplan J, Sarnaik S, Gillin J, Lusher J: Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions. Blood 1984:64:308-310.
23. Gascon P, Zountbos NC, Young NS: Immunologic abnormalities in patients receiving multiple blood transfusion. Ann Intern Med 1984; 100:173.
24. Sibrowski W, Wegner W, Kuhnl P: Immunomodulatory activity of different blood products on the mitogen-induced human lymphocyte transformation. T ransfus Med 1992:2:215.
25. Mathiesen O, Lund I, Brodthagen U, Gandrup P, Grunnel N, Balslev I, Jersild C: The effect of previous blood transfusion on lymphocyte subsets and natural killer cell function in patients with colorectal cancer. Vox Sang 1994; 67:36-41.
26. Nagarkatti PS, Joseph S, Singal DP: Induction of antibodies by blood transfusions capable of inhibiting responses in MLC. Transplantation I983;36:695.
27. Paglieroni TG, Ward J. Holland PV: Changes in peripheral blood CD5 [Bla] B-cell populations and autoantibodies following blood transfusion. Transfusion 1995:35:189-198.
28. Lenhard V, Gemsa D, Opelz G: Transfusion-induced release of prostaglandin E? and its role in the activation of T suppressor cells. Transplant Proc 1985; 17:2380-2382.
29. Shelby J: The roleofcicosanoids in the transfusion effect. Transplant Proc 1989:20:1217- 1218.
30. Brunson ME, Alexander JW: Mechanisms of transfusion-induced immunosuppression. Transfusion 1990;30:651-658.
31. Blumberg N, Heal JM: Effects of transfusion on immune function, cancer recurrence and infection. Arch Pathol Lab Med 1994,118: 371-379.
32. Tartter PI, Francis DMA: Blood transfusion and tumor growth. Transplant Proc 1988:20: 1108-1177.
33. van Twuyver E, Mooijaart RJD, Ten Berge IJM, et al: Pretransplantation blood transfusion revisited. N Engl J Med 1991:325:1210-1213.
34. Gantt CL: Red blood cells for cancer patients. Lancet 1981;ii:363.
35. Rosenberg SA, Yang JC, Topalina SL, et al: Treatment of 283 consecutive patients with metastatic melanoma or renal cancer using high dose bolus interleukin-2. JAMA 1994:271: 907-913.
36. Francis DMA, Shenton BK: Blood transfusion and tumour growth, evidence for laboratory animals. Lancet 1981;ii:871.
37. Jeckcl J, Eggermont A, Heystek GA. Marquel RL: Inhibition of tumor growth by blood transfusions in the rat. Eur Surg Res 1982:14:114-115.
38. Oikawa T, Hosokawa M, Immamura M, et al: Anti-tumor immunity by normal allogeneic blood transfusions in the rat. Clin Exp Immunol 1977:27:549-554.
39. Clarke PJ, Tarin D: Effect of peri-operative blood transfusion on tumour métastases. Br J Surg 1987:74:520-524.
40. Singh SK: Modification of Tumor Growth by Blood Transfusion and Perioperative Procedures: A Study in Rats: thesis Erasmus University. Rotterdam. 1988.
41. Marquet RL, de Bruin RWF, Dallinga R, Singh SK, Jeekel J: Modulation of tumor growth by allogeneic blood transfusion. J Cancer Res Clin Oncol 1986:111:50-53.
42. Zeller WJ, Scholler P, Robler W, et al: Allogeneic blood transfusions and experimental tumor growth. Transplant Proc 1986; 18:1448-1449.
43. Blajchman MA, Bardossy L, Carmen R, et al: Allogeneic blood transfusion induced enhancement of tumor growth: Two animal models showing amelioration by leucodepletion and passive transfer using spleen cells. Blood 1993: 81:1880-1882.
44. Marquet RL, Busch ORC, Singh SK, Hovnek van Papcndrecht P, Jeekel J: The influence of anesthesia. Surgery, blood loss and transfusion on immunity and tumor growth in an animal model: in Houbiers JGA (ed): Blood Transfusion in Cancer Surgery. Leiden Boerhaave Committee 1993; pp 49-62.
45. Singh SK, Marquet RL, Westbrock DL, Jeekel J: Enhanced tumor growth of artificial tumor métastasés following blood transfusion: The effect of erythrocytes, leucocytes and plasma transfusion. Eur J Cancer Clin Oncol 1987;23: 1537-1540.
46. Singh SK, Marquet RL, de Bruin RW, Hop WC, Westbrock DL, Jeckel J: Consequences of blood loss on artificial métastasés. Br J Surg 1988:75:377-379.
47. Hoynck van Papendrecht MAW, Busch ORC, Jeekel J. Marquet RL: The influence of blood loss on tumour growth: Effect and mechanism in an experimental model. Netlt J Surg 1991; 43:85-88.
48. Burrows L, Tartter P: Effect of blood transfusion on colonic malignancy recurrence rate. Lancet 1982;ii:662.
49. Tartter P: Pcrioperalicve blood transfusion and colorectal cancer recurrence: A review. J Surg Oncol 1988:39:197-200.
50. Wu HS, Little AG: Perioperative blood transfusion and cancer recurrence. J Clin Oncol 1988:6:1348-1354.
51. Schriemer PA, Longnecker DE, Mintz PD: The possible immunosuppressive effects of perioperative blood transfusion in cancer patients. Anesthesiology 1988;68:422-428.
52. Blumberg N, Heal JM: Transfusion and host defenses against cancer recurrence and infection. Transfusion 1989;29:236-245.
53. Francis DMA: Relation between blood transfusion and tumour behavior. Br J Surg 1991:78: 1420-1428.
54. Houbiers JGA: Blood Transfusion. Immune Response and Colorectal Cancer, thesis. University of Leiden 1994.
55. Garau I, Benito E, Bosch FX, Bargay J, Obrador A, Santamaría J, Antich JL, Bcsalduch J. Rifaj J. Teuchmann S: Blood transfusion has no effect on colorectal cancer survival. A population based study. Eur J Cancer 1994:30A: 759-764.
56. Blair SD, Janvrin SB: Relation between cancer if the colon and blood transfusion. Br Med J 1985;290:1516-1517.
57. Hodgson WJB, Lowenfels AB: Blood transfusion and recurrence rates in colonic malignancy. Lancet 1982;ii: 1047.
58. Parrot NR, Lennard TW, Taylor RM, et al: Effect of pcroperativc blood transfusion on recurrence of colorectal cancer. Br J Surg 1986: 73:970-973.
59. Heiss MM, Mempel W, Delanoff C, Jauch KW, Gabka C, Mempel M, Dielerieh HJ, Eissner HJ, Schildberg FW: Blood transfusion modulated tumor recurrence: First results of a randomized study of autologous versus allogeneic blood transfusion in colorectal surgery. J Clin Oncol 1994;12:1859-1867.
60. Busch ORC, Hop WCJ, Hoynekvan Papendrecht MAW, Marquet RL, Jeekel J: Blood transfusions and prognosis in colorectal cancer. N Engl J Med 1993;328:1372-1376.
61. Houbiers JGA, Brand A, van de Watering LMG, Hermans J, Verwey PJM, Bijnen AB. Pahlplatz P, et al: Randomized controlled trial comparing transfusion of leucocyte-depleted or buffy coat-depleted blood in surgery for colorectal cancer. Lancet 1994;344:573-578.
62. Chaudry IH, Ayala A, Ertel W, Stephan RN: Hemorrhage and resuscitation: Immunological aspects. Am J Physiol 1990,259:663-678.
63. Chaudry IH, Ayala A: Mechanism of increased susceptibility to infection after hemorrhage. Am J Surg 1993; 165:(suppl 2A):59-67.
64. Ayala A, Lehman DL, Herdon CD, Chaudry IH: Mechanism of enhanced susceptibility to sepsis following hemorrhage. Interleukin-10 suppression of T-cell response is mediated by eicosanoid-induced interleukin-4 release. Arch Surg 1994; 129: 1172-1179.
65. Yago H, Yoshii H, Naiki M, Suehiro S: Stress and murine NK cell function. The role of blood loss. J Clin Lab Immunol 1992:37:123-132.
66. Singh SK, Marquet RL, de Bruin RWF, Hop WCJ, Weslbroek DL, Jeekel J: Consequences of blood loss on growth of artificial metastasis. BrJ Surg 1988;75:377-379.
67. Hoynck van Papendrecht MAW, Busch ORC, Jeekel J, Marquet RL: The influence of blood loss on tumour growth: Effect and mechanism in an experimental model. Neth J Surg 1991: 43:85-88.
68. Younes RN, Rogatko A, Nadarajen A, Vyde-lingum NA, Brennan MF: Effects of hypovolemia and transfusion on tumor growth in MCA-tumor-bearing rats. Surgery 1991:109: 307-312.
69. Oldham RK: Natural killer cells: History, relevance and clinical application. Nat Immun Cell Growth Regul 1990;9:297-312.
70. Hcrberman RB, Ortaldo JR: Natural killer cells: Their roles in defense against disease. Science 1981:214:24-30.
71. Tartter PL Steinberg B, Barron DM, Martinelli G: The prognostic significance of natural killer cytotoxicity in patients with colorectal cancer. Arch Surg 1987;122:1264-1268.
72. Marquet RL, Hoynek van Papendrecht MAW, Busch ORC, Jeekel J: Blood donation leads to a decrease in natural killer cell activity: A study in normal blood donors and cancer patients. Transfusion 1993;33:368-373.
73. Busch ORC, Lonl HE, Hop WCJ, Marquet RL, Jeekel J: The effect of blood donation on prognosis and infectious complications after colorectal cancer surgery. Submitted for publication.
74. Alexander JW: Transfusion-induced immuno-ntodulation and infection. Transfusion 1991; 31:195-196.
75. Blumberg, Heal JM: Transfusion induced im-munomodulation and its possible role in cancer recurrence and perioperative bacterial infection. Yale J Biol Med 1990;63:429-433.
76. Tartter PI: Blood transfusions and infectious complications following colorectal cancer surgery. BrJ Surg 1988;75:789-792.
77. Wobbes T, Bemelmans BIH, Kuypers JHC, Beerthuyzen GIJM, Theewes AGM: Risk of postoperative septic complications after abdominal surgical treatment in relation to perioperative blood transfusion. Surg Gynecol Ob-stet 1990;171:59-62.
78. Nicols RL, Smith JW, Klein DB. et al: Risk of infection after penetrating abdominal trauma. N Engl J Med 1984:311:1065-1070.
79. Polk HC, George CD, Willhausen SR, et al: A systematic study of host defense processes in badly injured patients. Ann Surg 1986:204: 282-299.
80. Christou NV, Meakins JL, Gotto D, MacLean LD: Influence of gastrointestinal bleeding on host defense and susceptibility to infection. Surg Forum 1979;30:46-47.
81. Waymack JP, Rapien J, Garnett D, Tweddel JS, Alexander TW: Effect of transfusion on immune function in a traumatized animal model. Arch Surg 1986;121:50-55.
82. Waymack JP, Warden GD, Alexander JW, Miskell P, Gonee S: Effect of blood transfusion and anesthesia on resistance to bacterial peritonitis. J Surg Res 1987:42:528-535.
83. Heiss MM, Mempel W, Jauch KW, et al: Beneficial effect of autologous blood transfusion on infectious complications after colorectal surgery. Lancet 1993;342:1328-1333.